| __timestamp | Taro Pharmaceutical Industries Ltd. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 580006000 | 519428000 |
| Thursday, January 1, 2015 | 676585000 | 906794000 |
| Friday, January 1, 2016 | 778966000 | 1491717000 |
| Sunday, January 1, 2017 | 671251000 | 2213533000 |
| Monday, January 1, 2018 | 463508000 | 2638058000 |
| Tuesday, January 1, 2019 | 445724000 | 3615063000 |
| Wednesday, January 1, 2020 | 399725000 | 5469383000 |
| Friday, January 1, 2021 | 296656000 | 6670200000 |
| Saturday, January 1, 2022 | 293122000 | 7850400000 |
| Sunday, January 1, 2023 | 268323000 | 8607000000 |
| Monday, January 1, 2024 | 304979000 | 9489600000 |
Data in motion
In the competitive landscape of pharmaceuticals, Vertex Pharmaceuticals Incorporated and Taro Pharmaceutical Industries Ltd. have showcased contrasting trajectories in gross profit over the past decade. From 2014 to 2023, Vertex Pharmaceuticals has demonstrated a remarkable growth, with its gross profit surging by over 1,500%, peaking at approximately $8.6 billion in 2023. This growth reflects Vertex's strategic advancements in innovative treatments and market expansion.
Conversely, Taro Pharmaceuticals experienced a decline of about 54% in gross profit, dropping from its 2016 peak to around $268 million in 2023. This downturn highlights the challenges faced by Taro in maintaining its market position amidst increasing competition and regulatory pressures.
The data for 2024 remains incomplete, offering a glimpse into the uncertainties and potential shifts in the pharmaceutical industry. As these companies navigate the evolving market, their financial performances will continue to be a focal point for investors and analysts alike.
Johnson & Johnson vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Sanofi vs Vertex Pharmaceuticals Incorporated: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs Taro Pharmaceutical Industries Ltd.
Gross Profit Comparison: Vertex Pharmaceuticals Incorporated and Takeda Pharmaceutical Company Limited Trends
Key Insights on Gross Profit: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Who Generates Higher Gross Profit? Vertex Pharmaceuticals Incorporated or Lantheus Holdings, Inc.
Key Insights on Gross Profit: Vertex Pharmaceuticals Incorporated vs Perrigo Company plc
Gross Profit Analysis: Comparing Vertex Pharmaceuticals Incorporated and Arrowhead Pharmaceuticals, Inc.
Gross Profit Comparison: Genmab A/S and Taro Pharmaceutical Industries Ltd. Trends
Pharming Group N.V. vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Bausch Health Companies Inc. vs Taro Pharmaceutical Industries Ltd.
Gross Profit Analysis: Comparing Taro Pharmaceutical Industries Ltd. and MiMedx Group, Inc.